Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab

BACKGROUND/AIMS: The aim of our study was to determine the incidence and clinical features of severe pulmonary complications in patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab plus CHOP (R-CHOP) as the initial treatment for lymphoma. METHODS: A retro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lim, Kyu-Hyoung, Yoon, Ho-Il, Kang, Young Ae, Lee, Keun-Wook, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jae Ho, Lee, Choon-Taek, Lee, Jong Seok
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association of Internal Medicine 2010
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2829422/
https://ncbi.nlm.nih.gov/pubmed/20195409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2010.25.1.86
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items